Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Correct. On the scientific advisory committee. The board of directors has one member.
Last I checked he was still with Entest advisory but their website has not been updated in quite some time.
That requirement does not paint the picture any more pretty. Koos is flying alone, by the seat of his pants. A one person board in never desired.
Barlie- there is no ENTB board. Its only Koos. Do some DD.
Right but with little confidence left by shareholders and potential vets going out of business is certainly on the table.
Besides what clinic owner would ever consider entering into a project with ENTB at this point? They can't complete their little safety study much less conduct any real scientific testing. MEDS is using stem cells as a source to fight disease and build their company while ENTB does nothing with stem cells. We really don't even knowthe level of involvement ENTB had has the MEDS project at this point. I would not be surprised to see that dissolve like the Oregon agreement.
Yes but none of that is going to keep ENTB from going under at this point. You can no longer deny that there is dilution.
Well there is certainly one thing that we completely agree on. Greed kills. Koos greed killed ENTB.
= lots of debt, little revenue
There has only been one acquisition. I have done my homework too.
Now some of that turns out to be false. This is not Asher as the chat has "informed" you. This is pure dilution. If you ever actually came in contact with Koos and he told you the share structure would not increase- he lied.
Yeah, that was a hard call to make given it had been sitting just above a penny for 5 trading sessions.
That is unlikely.
I just thought up that ENTB is going to 0.0001 within 12 months. There will be resistance by the believers but its over.
You still stand by that? Looks like those made it into the O/S.
You think this is Asher? Looks like a stink sheet dilution to me.
Thats why Koos has not been posting.
8K filed March 22
http://biz.yahoo.com/e/120322/entb.pk8-k.html
Great post.
Thanks for sharing that insight.
Paulness, This might help to clarify what I am talking about. I thought ENTB was treating dogs for cancer too but after discussing it with Casper and re-reading the PR's, I was wrong.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=72515194
If they are not looking at efficacy they cannot report it. That would be misleading. Without scientific rigor a study design is moot.
Consider the initiation of the imanvex implantation safety study over a year ago. Canines diagnosed with oral melanoma will live only 5-9 months from diagnosis (there are many links provided in previous posts). It had been well over a year and all we have heard is that there were no complications. If the dogs were alive we would know by now. Because it was not a treatment study there is no reason to hold back on us.
ENTB had treated no dogs for cancer. They planned the safety study and then announced it with insufficient funding. Please read Caspers posts from around the time you showed up on the board. There is nothing misleading about my posts.
I have no doubt about the power on stem cells at all. ENTB has not conducted any tests using stem cells on cancer. That test was only a safety study with three dogs, not ten. Statistical analysis is not possible on a sample size = 3. Even if they were to complete the safety study they still have to look at efficacy in a separate study and have independent observations. I understand the work they are helping MEDS with is moving forward but that is a separate entity.
Thanks for verifying.
I agree
O please. What about the seven dogs not in the study, the masses of clinics, etc? Moneys coming. Lawsuit is coming.
Careful, that is a safety study NOT an efficacy study. They are looking to see if the implantation works. Note: that study initiation date. Check out Casper's posts.
Fact: ENTB has not treated a single dog for cancer. Only a 3 dog safety study here.
He said there was not enough money because the treatments were too expensive. What a f----- joke. Lets announce a study we don't have enough money to fund.
I thought it was you who said they were out of money for more tests because they cost too much. My bad. It was Dr. Who.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=73049073
Please keep it to the facts. There are no new dogs being treated. Like Linedrive pointed out in an earlier post, Koos said they have no money for the safety study. ENTB has never actually treated a dog for cancer.
Just curious what new dogs are getting treated for cancer. Did I miss something? TIA
They can't be backed up bc either they don't say what we want to hear and a are being with held or they never happened. The emails could be shared bc anything the colonel says to a shareholder is public and he knows that. What is said on the phone could be different but still is subject to scrutiny if it were thought to be insider info. I have been lied to directly by CEO's of stinky pinks before. What would make this any different? Even if Koos is available as some claim it does not mean he isn't FOS.
Yeah but ENTB can't even complete a safety study. The MEDS folks seem to have it together though.
The 21st looks like more buys but yesterday does not. If your observation is true one would expect the pps to increase. It has not. That stinks of dilution.
Why don't you ever post those emails so the board can see them? Your claims are ALWAYS unsubstantiated. Please back them up.
Someone suggested that there are some chat histories that will show evidence of the P&D by STC and Stock Seasonality. I was never a member of these boards but used a friends account to enter both at one time. If anyone has some chat histories it would help build a case against them. It will be easy for them to see that those board members coaxing you into buying sold into your buys. Have a good weekend.
Investors are looking at this news and saying "huh, why can't ENTB do this with their own study?".
ENTB new all time low.